AI assistant
ARGO BLOCKCHAIN PLC — Regulatory Filings 2021
Nov 1, 2021
5008_dva_2021-11-01_371c0902-6e03-4cc3-9e69-11f9c1ecce4a.html
Regulatory Filings
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 8118Q
Valereum Blockchain PLC
01 November 2021
1 November 2021
Valereum Blockchain Plc
("Valereum" or the "Company")
Total Voting Rights
In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the Company hereby announces that it has 71,398,453 ordinary shares of 0.1 pence each ("Ordinary Shares") in issue, each share carrying the right to one vote.
The above figure of 71,398,453 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.
The Directors of Valereum Blockchain Plc take responsibility for this announcement.
END
Enquiries:
Valereum Blockchain Plc
Richard Poulden, Chairman
Tel: +971 4584 6284
AQSE Growth Market Corporate Adviser
Peterhouse Capital Limited
Mark Anwyl
Tel: +44 (0) 207 469 0930
Investor Relations
J&H Communications Limited
James Henderson
Tel: +44 (0)7774 444163
George Hudson
Tel: +44 (0)7803 603130
The website address of the Company is www.valereumblockchain.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NEXWPGQWUUPGGUG